Israel Luis Villavicencio Quevedo

Israel Luis Villavicencio Quevedo

Auto-generated profile, based on publicly available information

Israel Luis Villavicencio Quevedo

Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2025 in Mediciencias UTA
Verified
Journal Article
Open access
PDF file
JAJavier Aquiles Hidalgo Acosta
Javier Aquiles Hidalgo Acosta
RGRomina Ivanna Mendoza Granda
Romina Ivanna Mendoza Granda
IQIsrael Luis Villavicencio Quevedo
Israel Luis Villavicencio Quevedo
UVUrvina Muñoz Jefferson Vicente
Urvina Muñoz Jefferson Vicente
WZWagnner Ariol Intriago Zambrano
Wagnner Ariol Intriago Zambrano
Introduction: Neuroinfection is a serious cause of neurological disease, epidemiologically it is estimated that it affects 2.5 million people in the world, at any age, with greater prevalence in regions that lack vaccination programs, such as the African continent specifically in the area called meningitis belt, where there is a high prevalence of the disease. since it is considered a health problem of great relevance worldwide. Objectives: to conduct a systematic review on complications and mortality in neuroinfection. Materials and methods: Databases such as PubMed, Wiley, SciELO, BMC, Europe PMC, Latindex, Google Scholar were searched. Observational studies, multicenter studies, randomized trials, systemic reviews, and meta-analyses were included with the research topic with a total of 50 articles. Results: According to a meta-analysis of 157 656 published cases of bacterial meningitis, the highest case fatality rate was presented by meningitis caused by Listeria monocytogenes with 27%, pneumococci 24%, meningococci 9% and H. influenzae 11%, whereas, the immunization of individuals with risk factors or areas against invasive meningococcal disease caused by Neisseria meningitidis of groups A, C, Y, W and X is a priority. A retrospective study carried out at the Eugenio Espejo Hospital in Quito revealed that 58 patients with HIV and neuroinfection accounted for 13.27% of admissions, the clinical manifestations were characterized by altered state of consciousness in 25.86%, seizures in 20.7%, headache in 15.5%, neurological focality in 39.7% of cases. Conclusions: Neuroinfection is a common pathological state in patients with risk factors or exposed to risk areas where preventive immunization is deficient and represent susceptible populations that can generate infection in the brain, presenting high morbidity and mortality and important neurological sequelae. In our country, the largest number of patients with neuroinfection is expressed by patients suffering from the human immunodeficiency virus

5 September 2024 in INSPILIP
Verified
Journal Article
Open access
PDF file
KEKleber Eduardo González Echeverria
Kleber Eduardo González Echeverria
DLDavid Argenis Murrillo Loor
David Argenis Murrillo Loor
IQIsrael Luis Villavicencio Quevedo
Israel Luis Villavicencio Quevedo
PJPio Joel Cueva Jiménez
Pio Joel Cueva Jiménez
EPEsther María Vera Plaza
Esther María Vera Plaza
JAJavier Aquiles Hidalgo Acosta
Javier Aquiles Hidalgo Acosta
Se define un aneurisma cerebral, como una dilatación que ocurre en la circulación arterial, dentro del cerebro y se clasifican en: saculares, fusiformes y micóticas. Epidemiológicamente en Ecuador, los aneurismas son más frecuentes en el sexo femenino con un 68%, presentándose en el 90% en forma de rotura aguda y hemorragia subaracnoidea (HSA). Esta investigación tiene como objetivo describir dos casos clínicos de aneurismas cerebrales y su abordaje neuroquirúrgico, por cuanto, se presentan los casos de dos pacientes de sexo femenino con aneurisma cerebral roto y hemorragia subaracnoidea, localizados en arteria comunicante anterior y posterior respectivamente, cuyo tratamiento neuroquirúrgico fue mediante clipaje quirúrgico con resultado exitoso.

1 October 2025 in Mediciencias UTA
Verified
Journal Article
Open access
PDF file
JAJavier Aquiles Hidalgo Acosta
Javier Aquiles Hidalgo Acosta
WZWagnner Ariol Intriago Zambrano
Wagnner Ariol Intriago Zambrano
IQIsrael Luis Villavicencio Quevedo
Israel Luis Villavicencio Quevedo
EBEvelyn Lucero Capuz Balladares
Evelyn Lucero Capuz Balladares
MAMónica Piedad Moran Ayala
Mónica Piedad Moran Ayala
Introduction: vestibular schwannomatosis (SV), also known as acoustic neurinoma or NF2, is a genetic mutation in the NF2 gene located on chromosome 22, characterized by loss of function of a tumor suppressor protein that has several names among them: Merlin, Neurofibromin 2 and schwannomin. It is classified as a hereditary multiple neoplasm syndrome with an incidence of 1:25,000 to 1:40,000. Objectives: to determine the current management and progress in pharmacological treatment of vestibular Schwannomatosis Methods: a systematic search was carried out with the PRISMA 2020 statement of studies or research on VS, as search words were used the terms Schwannomatosis vestibular, Schwannoma vestibular, acoustic neuroma, published in the last 5 years. For the selection, observational studies, randomized and non-randomized clinical trials, systematic reviews and meta-analyses were used; studies with missing, unavailable data were excluded. Results: gamma-ray scalpel radiosurgery is a treatment that helps stabilize tumor growth and improves hearing. Stereotactic radiosurgery for vestibular schwannoma has a high tumor control rate of 90.7%, excellent preservation of the facial nerve and low incidence of tinnitus and vertigo. Surgical management with a low failure rate can be used for tumor recurrence. Conclusions: treatment with monoclonal antibodies such as bevacizumab is a breakthrough in research, whose mechanism of action allows acting as an antiangiogenic that inhibits the vascularization of tumors by slowing their development. The main goal of treatment is to stop the growth of the tumor, which can improve symptoms such as hearing loss. Response to treatment will depend on tumor size, location and associated symptomatology. The surgical approach consists of microsurgery or stereotactic surgery with good results.